Cancer Immunology and Immunotherapy – 2011
نویسنده: Glenn Dranoff | سال: 2011 | ویرایش: 1st
تحویل اکسپرس
حمل رایگان سفارشات بالای 1 میلیون تومان
پرداخت امن
امکان پرداخت انلاین یا پرداخت حضروی درب منزل
ضمانت اصالت کالا
امکان پرداخت انلاین یا پرداخت حضروی درب منزل
7 روز گارانتی بازگشت وجه
امکان پرداخت انلاین یا پرداخت حضروی درب منزل
The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.
- نویسنده: Glenn Dranoff
- شابک: 9783642141355
- کد کالا: 105357
- سال: 2011
- ویرایش: 1st
| نوع نسخه | نسخه الکترونیکی (PDF), نسخه چاپی |
|---|---|
| سال انتشار | 2011 |
محصولات مشابه

Review of Medical Microbiology and Immunology – 2018

Suppression and Regulation of Immune Responses: Methods and Protocols – 2016


A Historical Perspective on Evidence-Based Immunology – 2016

Immunology & Serology in Laboratory Medicine – 2014


نقد و بررسیها
هنوز بررسیای ثبت نشده است.